dc.contributor.author |
Sjaarda L.A. |
dc.contributor.author |
Michaliszyn S.F. |
dc.contributor.author |
Lee S. |
dc.contributor.author |
Tfayli H. |
dc.contributor.author |
Bacha F. |
dc.contributor.author |
Farchoukh L. |
dc.contributor.author |
Arslanian S.A. |
dc.contributor.editor |
|
dc.date |
Dec-2012 |
dc.date.accessioned |
2017-10-05T16:01:17Z |
dc.date.available |
2017-10-05T16:01:17Z |
dc.date.issued |
2012 |
dc.identifier |
10.2337/dc12-0747 |
dc.identifier.isbn |
|
dc.identifier.issn |
01495992 |
dc.identifier.uri |
http://hdl.handle.net/10938/19409 |
dc.description.abstract |
OBJECTIVE - The recommended HbA1c diagnostic categories remain controversial and their utility in doubt in pediatrics. We hypothesized that alterations in the pathophysiologic mechanisms of type 2 diabetes may be evident in the American Diabetes Association recommended at-risk-prediabetes category (HbA1c 5.7 to andlt;6.5percent). RESEARCH DESIGN AND METHODS - We compared in vivo hepatic and peripheral insulin sensitivity by [6,6-2H 2] glucose and a 3-h hyperinsulinemic-euglycemic clamp and β-cell function by a 2-h hyperglycemic clamp (∼225 mg-dL) in overweight-obese (BMI ≥85th percentile) adolescents with prediabetes (HbA1c 5.7 to andlt;6.5percent) (n = 160) to those with normal HbA 1c (andlt;5.7percent) (n = 44). β-Cell function was expressed relative to insulin sensitivity (i.e., the disposition index = insulin sensitivity X first-phase insulin). RESULTS - In the prediabetes versus normal HbA 1c category, fasting glucose, insulin, and oral glucose tolerance test (OGTT) area under the curve for glucose and insulin were significantly higher; hepatic and peripheral insulin sensitivity were lower; and β-cell function relative to insulin sensitivity was lower (366 ± 48 vs. 524 ± 25 mg-kg-min; P = 0.005). A total of 27percent of youth in the normal HbA1c category and 41percent in the prediabetes HbA1c category had dysglycemia (impaired fasting glucose and-or impaired glucose tolerance) by a 2-h OGTT. CONCLUSIONS - Overweight-obese adolescents with HbA1c in the at-risk-prediabetes category demonstrate impaired β-cell function relative to insulin sensitivity, a metabolic marker for heightened risk of type 2 diabetes. Thus, HbA1c may be a suitable screening tool in large-scale epidemiological observational and-or interventional studies examining the progression or reversal of type 2 diabetes risk. © 2012 by the American Diabetes Association. |
dc.format.extent |
|
dc.format.extent |
Pages: (2559-2563) |
dc.language |
English |
dc.publisher |
ALEXANDRIA |
dc.relation.ispartof |
Publication Name: Diabetes Care; Publication Year: 2012; Volume: 35; no. 12; Pages: (2559-2563); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
HbA1c diagnostic categories and β-cell function relative to insulin sensitivity in overweight-obese adolescents |
dc.type |
Article |
dc.contributor.affiliation |
Sjaarda, L.A., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States |
dc.contributor.affiliation |
Michaliszyn, S.F., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States |
dc.contributor.affiliation |
Lee, S., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States |
dc.contributor.affiliation |
Tfayli, H., Department of Pediatrics and Adolescent Medicine, Pediatric Endocrinology, American University of Beirut, Beirut, Lebanon |
dc.contributor.affiliation |
Bacha, F., Department of Pediatrics, Baylor College of Medicine, Houston, TX, United States |
dc.contributor.affiliation |
Farchoukh, L., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States |
dc.contributor.affiliation |
Arslanian, S.A., Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States, Division of Pediatric Endocrinology, Metabolism and Diabetes Mellitus, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States |
dc.contributor.authorAddress |
Arslanian, S.A.; Division of Weight Management and Wellness, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA, United States; email: silva.arslanian@chp.edu |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pediatrics and Adolescent Medicine; |
dc.contributor.authorDepartment |
Pediatrics and Adolescent Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
silva.arslanian@chp.edu |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Sjaarda, LA |
dc.contributor.authorInitials |
Michaliszyn, SF |
dc.contributor.authorInitials |
Lee, S |
dc.contributor.authorInitials |
Tfayli, H |
dc.contributor.authorInitials |
Bacha, F |
dc.contributor.authorInitials |
Farchoukh, L |
dc.contributor.authorInitials |
Arslanian, SA |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Arslanian, SA (reprint author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Weight Management and Wellness, Pittsburgh, PA 15213 USA. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337-dc06-1331; American Diabetes Association, 2010, DIABETES CARE S1, V33, pS11, DOI DOI 10.2337-DC10-S011; Arslanian SA, 2005, HORM RES, V64, P16, DOI 10.1159-000089313; Arslanian SA, 2002, DIABETES, V51, P3014, DOI 10.2337-diabetes.51.10.3014; Bacha F, 2010, DIABETES CARE, V33, P2225, DOI 10.2337-dc10-0004; Bacha F, 2008, J PEDIATR, V152, P618, DOI 10.1016-j.jpeds.2007.11.044; Bacha F, 2004, DIABETES CARE, V27, P547, DOI 10.2337-diacare.27.2.547; Bacha F, 2009, DIABETES CARE, V32, P100, DOI 10.2337-dc08-1030; Burns SF, 2009, DIABETES CARE, V32, P2087, DOI 10.2337-dc09-0380; Buse JB, 2010, DIABETES CARE, V33, pe175; Buse John B, 2010, Diabetes Care, V33, pe175, DOI 10.2337-dc10-1720; Cali AMG, 2009, DIABETES CARE, V32, P456, DOI 10.2337-dc08-1274; Cnop M, 2007, DIABETES CARE, V30, P677, DOI 10.2337-dc06-1834; D'Adamo E, 2011, DIABETES CARE, V34, pS161, DOI 10.2337-dc11-s212; Fonseca V, 2009, DIABETES CARE, V32, P1344, DOI 10.2337-dc09-9034; George L, 2011, J CLIN ENDOCR METAB, V96, P2136, DOI 10.1210-jc.2010-2813; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016-S0140-6736(11)60472-8; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337-dc06-2003; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337-dc09-9033; Lee JM, 2011, J PEDIATR-US, V158, P947, DOI 10.1016-j.jpeds.2010.11.026; Lee JM, 2011, J PEDIAT, V158, pe1; Lee JM, 2011, DIABETES CARE, V34, P2597, DOI 10.2337-dc11-0827; Lee S, 2010, J CLIN ENDOCR METAB, V95, P2426, DOI 10.1210-jc.2009-2175; Libman IM, 2008, J CLIN ENDOCR METAB, V93, P4231, DOI 10.1210-jc.2008-0801; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337-diabetes.54.1.166; Malkani S, 2011, AM J MED, V124, P395, DOI 10.1016-j.amjmed.2010.11.025; Misra A, 2011, LANCET, V378, P104, DOI 10.1016-S0140-6736(11)60789-7; Nowicka P, 2011, DIABETES CARE, V34, P1306, DOI 10.2337-dc10-1984; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337-dc10-0433; Rosner B, 1998, J PEDIATR, V132, P211, DOI 10.1016-S0022-3476(98)70434-2; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337-dc10-1235; Sjaarda LG, 2012, J PEDIATR-US, V161, P51, DOI 10.1016-j.jpeds.2011.12.050; Tanner J.M., 1969, ENDOCRINE GENETIC DI, P19; Tfayli H, 2009, DIABETES, V58, P738, DOI 10.2337-db08-1372; Tfayli H, 2010, DIABETES CARE, V33, P632, DOI 10.2337-dc09-0305; Utzschneider KM, 2009, DIABETES CARE, V32, P335, DOI 10.2337-dc08-1478 |
dc.description.citedCount |
9 |
dc.description.citedTotWOSCount |
12 |
dc.description.citedWOSCount |
11 |
dc.format.extentCount |
5 |
dc.identifier.articleNo |
|
dc.identifier.coden |
DICAD |
dc.identifier.pubmedID |
22912428 |
dc.identifier.scopusID |
84869791844 |
dc.identifier.url |
|
dc.publisher.address |
1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Diabetes Care |
dc.relation.ispartOfIssue |
12 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Diabetes Care |
dc.relation.ispartofPubTitleAbbr |
Diabetes Care |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
35 |
dc.source.ID |
WOS:000311426000041 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
glucose, 50-99-7, 84778-64-3 |
dc.subject.otherChemCAS |
hemoglobin A1c, 62572-11-6 |
dc.subject.otherChemCAS |
insulin, 9004-10-8 |
dc.subject.otherChemCAS |
Blood Glucose |
dc.subject.otherChemCAS |
Hemoglobin A, Glycosylated |
dc.subject.otherIndex |
glucose |
dc.subject.otherIndex |
hemoglobin A1c |
dc.subject.otherIndex |
insulin |
dc.subject.otherIndex |
adolescent |
dc.subject.otherIndex |
adult |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
child |
dc.subject.otherIndex |
controlled study |
dc.subject.otherIndex |
dysglycemia |
dc.subject.otherIndex |
female |
dc.subject.otherIndex |
glucose clamp technique |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
impaired glucose tolerance |
dc.subject.otherIndex |
insulin sensitivity |
dc.subject.otherIndex |
major clinical study |
dc.subject.otherIndex |
male |
dc.subject.otherIndex |
non insulin dependent diabetes mellitus |
dc.subject.otherIndex |
obesity |
dc.subject.otherIndex |
oral glucose tolerance test |
dc.subject.otherIndex |
pancreas islet beta cell |
dc.subject.otherIndex |
school child |
dc.subject.otherIndex |
Adolescent |
dc.subject.otherIndex |
Adult |
dc.subject.otherIndex |
Blood Glucose |
dc.subject.otherIndex |
Child |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Glucose Clamp Technique |
dc.subject.otherIndex |
Hemoglobin A, Glycosylated |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Insulin Resistance |
dc.subject.otherIndex |
Insulin-Secreting Cells |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Obesity |
dc.subject.otherIndex |
Overweight |
dc.subject.otherIndex |
Young Adult |
dc.subject.otherKeywordPlus |
IMPAIRED GLUCOSE-TOLERANCE |
dc.subject.otherKeywordPlus |
ORAL DISPOSITION INDEX |
dc.subject.otherKeywordPlus |
OBESE YOUTH |
dc.subject.otherKeywordPlus |
SECRETION |
dc.subject.otherKeywordPlus |
CHILDREN |
dc.subject.otherKeywordPlus |
A1C |
dc.subject.otherKeywordPlus |
HEMOGLOBIN |
dc.subject.otherKeywordPlus |
SPECTRUM |
dc.subject.otherWOS |
Endocrinology and Metabolism |